Sayana Press® is a progestogen-only injectable contraceptive licensed for subcutaneous use. It contains 104mg of medroxyprogesterone acetate (MPA) in 0.65ml suspension and is bioequivalent to IM depot medroxyprogesterone acetate. It is administered at intervals of 13 weeks +/- 7 days via a new delivery system (Unijet) – a single dose pre-filled injector. Although ideal for […]
Latest articles
GUNA Summer Meeting
GUNA Summer Clinical Meeting – Shaping Best Practice GUNA is holding its summer meeting on 28th June at Jury’s Inn Hotel, Islington. The GUNA summer clinical meeting for 2013 is being held on Friday 28th June and focuses on ‘Shaping Best Practice.’ Bringing together some of the UK’s most renowned sexual health practitioners, […]
Copenhagen Impressions
European Society of Contraception and Reproductive Health First Global Conference Highlights of the Congress included: Crown Princess Mary opening the Congress followed by the amazing Copenhagen drummers Green contraception – estrogen in water an issue, rating methods for their ‘greenness’: hormones, packaging etc. Lidegaard / Shulman / Dinger – continuing debate on […]
International Campaign for Women’s Right to Safe Abortion launches new website
The International Campaign for Women’s Right to Safe Abortion was launched on the International Day of Action for Women’s Health on 28 May 2012. Now, one year later , it announced the launch of its new website which aims to raise awareness particularly linked to the September 28 Global Day of Action for access to […]
Online First articles
Use of UPA, LNG and the copper IUD for EC following the introduction of new FSRH guidelines This paper reports a notes review of emergency contraception (EC) prescription before and after the release of the Faculty guidelines in early 2012. It is interesting that Levonelle® remains a popular choice, possibly because there is less interference […]
DH Consultation on publication of abortion statistics
The Department of Health (DH) is proposing changes to the way it publishes abortion statistics for England and Wales, and is seeking the views of commissioners, clinicians, academics and other government departments and special interest groups. The consultation is open until 10 June 2013. The aim of the consultation is to ensure that the abortion […]
Help WHO revise its guidelines!
The WHO are currently preparing updates to its Medical Eligibility Criteria for Contraceptive Use and Selected Practice Recommendations for Contraceptive Use, which will be finalized in 2014, and are soliciting feedback from various stakeholders in the field of family planning to inform this process. The goal is to ensure these guidelines remain relevant to family planning […]
Venous thrombo-embolism and the COC – an ongoing saga
This ongoing controversy recently resulted in the decision of the French authorities to withdraw the COC containing ethinylestradiol (EE) and cyproterone acetate (CPA) ie Diane 35 from the market. Just published online in the JFPRHC is a joint statement from 26 international experts in contraception, whose conclusion is: ‘Both epidemiological data and clinical trials must […]
US Judge orders FDA to make Morning-After Pill available over the counter for all
Judge Strikes Down Age Limits on Morning-After Pill A federal judge has ruled that the Unites States government must make the most common morning-after pill available over the counter for all ages, instead of requiring a prescription for girls 16 and under. The New York Times reported that the decision, on a fraught and politically […]
April Journal – 20th Anniversary of the FSRH
Hightlights from this edition include: The FSRH’s 20th anniversary It is 20 years since the establishment of the Faculty of Sexual and Reproductive Healthcare (FSRH). In celebrating its anniversary there is much to be proud of, and indeed Community Sexual and Reproductive Health is now a specialty in its own right. Readers should find the story […]